rs202022529

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_172364.5(CACNA2D4):​c.2921+7G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000477 in 1,613,880 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00027 ( 2 hom. )

Consequence

CACNA2D4
NM_172364.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00004731
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.332

Publications

1 publications found
Variant links:
Genes affected
CACNA2D4 (HGNC:20202): (calcium voltage-gated channel auxiliary subunit alpha2delta 4) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
CACNA2D4 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinal cone dystrophy 4
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 12-1800379-C-G is Benign according to our data. Variant chr12-1800379-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96534.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,Unknown,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D4NM_172364.5 linkc.2921+7G>C splice_region_variant, intron_variant Intron 32 of 37 ENST00000382722.10 NP_758952.4 Q7Z3S7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D4ENST00000382722.10 linkc.2921+7G>C splice_region_variant, intron_variant Intron 32 of 37 1 NM_172364.5 ENSP00000372169.4 Q7Z3S7-1
CACNA2D4ENST00000586184.5 linkc.2921+7G>C splice_region_variant, intron_variant Intron 32 of 36 5 ENSP00000465060.1 Q7Z3S7-5
CACNA2D4ENST00000587995.5 linkc.2846+7G>C splice_region_variant, intron_variant Intron 31 of 36 5 ENSP00000465372.1 K7EJY1
CACNA2D4ENST00000585708.5 linkc.2729+7G>C splice_region_variant, intron_variant Intron 32 of 36 5 ENSP00000467697.1 Q7Z3S7-6
CACNA2D4ENST00000588077.5 linkc.2729+7G>C splice_region_variant, intron_variant Intron 32 of 37 5 ENSP00000468530.1 Q7Z3S7-4
CACNA2D4ENST00000536846.6 linkc.359+7G>C splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000468167.1 K7ER98
CACNA2D4ENST00000538027.6 linkc.356+7G>C splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000443038.2 X6RLY7
CACNA2D4ENST00000538450.5 linkc.311+7G>C splice_region_variant, intron_variant Intron 5 of 10 2 ENSP00000446341.1 B4DVU4
CACNA2D4ENST00000444595.6 linkn.*1105+7G>C splice_region_variant, intron_variant Intron 31 of 36 1 ENSP00000403371.2 E7EUE0
CACNA2D4ENST00000537784.5 linkn.*114+7G>C splice_region_variant, intron_variant Intron 9 of 14 1 ENSP00000440231.2 X6RLU5
CACNA2D4ENST00000545595.6 linkn.*114+7G>C splice_region_variant, intron_variant Intron 4 of 9 1 ENSP00000442329.2 Q7Z3S7-7
CACNA2D4ENST00000585385.5 linkn.*114+7G>C splice_region_variant, intron_variant Intron 5 of 10 5 ENSP00000467333.1 K7EIY9

Frequencies

GnomAD3 genomes
AF:
0.00246
AC:
375
AN:
152178
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00859
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000619
AC:
153
AN:
247096
AF XY:
0.000477
show subpopulations
Gnomad AFR exome
AF:
0.00873
Gnomad AMR exome
AF:
0.000348
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000361
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000270
AC:
394
AN:
1461584
Hom.:
2
Cov.:
32
AF XY:
0.000239
AC XY:
174
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.00956
AC:
320
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53394
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000899
AC:
10
AN:
1111762
Other (OTH)
AF:
0.000762
AC:
46
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00247
AC:
376
AN:
152296
Hom.:
1
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.00859
AC:
357
AN:
41542
American (AMR)
AF:
0.000719
AC:
11
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000291
Hom.:
0
Bravo
AF:
0.00300
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal cone dystrophy 4 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
7.3
DANN
Benign
0.48
PhyloP100
0.33
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000047
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202022529; hg19: chr12-1909545; API